| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0802 |
| Trial ID | ChiCTR1900023500 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UCAR-T-19 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Targeting CD19 universal chimeric antigen receptor T cells (UCART-19) in refractory/relapsed B-cell acute lymphoblastic leukemia and aggressive lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | Guangdong Second Provincial General Hospital |
| Cohort 1 | |||||||
|
|||||||